...
首页> 外文期刊>Informatics in Medicine Unlocked >A rule extraction approach to explore the upper limit of hemoglobin during anemia treatment in patients with predialysis chronic kidney disease
【24h】

A rule extraction approach to explore the upper limit of hemoglobin during anemia treatment in patients with predialysis chronic kidney disease

机译:探讨血红蛋白血红蛋白上限血红蛋白血红蛋白患者血红蛋白患者血红蛋白血红蛋白血红蛋白的上限

获取原文
           

摘要

BackgroundIn patients with predialysis chronic kidney disease (CKD) and anemia, maintaining appropriate hemoglobin (Hb) levels during treatment for renal anemia is critical. The risk of cardiovascular events increases when target Hb levels are ≥13?g/dL. However, few studies have extensively assessed the upper limit of Hb levels in renal anemia clinics. Therefore, considering the importance of variations in Hb levels, the aim of the present study was to explore the upper limit of Hb levels during anemia treatment in predialysis CKD patients utilizing rule extraction.MethodsData were obtained from the University of California–Irvine Machine Learning Repository. Patients with >2.0?mg/dL of serum creatinine were excluded from the analysis. The remaining 243 patients were classified into either a predialysis CKD group (n?=?100) or a non-predialysis CKD (stages 1 and 2) group (n?=?143). We explored the upper limit of Hb levels during anemia treatment in predialysis CKD patients utilizing rule extraction. The Recursive-Rule eXtraction (Re-RX) algorithm with J48graft was used to extract the classification rules.ResultsThree concrete and concise derived rules were used for anemia treatment. Re-RX with J48graft showed very high classification accuracy (95.18%) for the test dataset and a larger area under the receiver operating characteristic curve (94.4%) using 10 runs of 5-fold cross-validation. We also found an upper-limit Hb level of 12.9?g/dL during anemia treatment utilizing rule extraction to help avoid the risk of cardiovascular events.ConclusionsTo the best of our knowledge, this is the first study using rule extraction to explore the upper-limit Hb level to maintain during renal anemia treatment.
机译:背景患者患有预脂溶性肾病(CKD)和贫血,在治疗肾贫血期间保持适当的血红蛋白(HB)水平至关重要。当靶HB水平≥13Ω时,心血管事件的风险增加。然而,很少有研究过广泛评估肾贫血诊所的HB水平的上限。因此,考虑到Hb水平变异的重要性,本研究的目的是探讨利用规则提取的预先血清患者贫血治疗期间HB水平的上限。从加州大学 - 欧文机器学习储存库中获得了方法。患有> 2.0?Mg / DL的血清肌酐被排除在分析之外。将剩余的243名患者分为预先分类为预析性CKD组(N?=α100)或非预析性CKD(阶段1和2)组(n?=?143)。我们探讨了利用规则提取的预缺血性CKD患者的贫血处理期间HB水平的上限。使用J48Gro移植的递归规则提取(RE-RX)算法用于提取分类规则。方法和简洁的衍生规则用于贫血处理。 RE-RX使用J48GROFTER显示了测试数据集的高分类精度(95.18%),并且使用10个5倍交叉验证的接收器操作特性曲线(94.4%)下的较大区域。我们还发现了12.9的上限hb水平为12.9?g / dl在贫血处理中利用规则提取,帮助避免心血管事件的风险。结论我们所知的最佳知识,这是第一次使用规则提取来探索上限的研究限制HB水平以维持肾贫血治疗。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号